Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,161 Cr
down ₹754 Cr vs Dec 2024
- Stocks held
- 37
- up 1 vs Dec 2024
- Top 10 weight
- 60.7%
- of the portfolio in its ten largest
- Cash & debt
- 1.4%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 4, trimmed 31
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In January 2025 it disclosed 37 stocks worth ₹8,161 Cr, down ₹754 Cr from Dec 2024. Its largest positions were Sun Pharmaceutical Industries Limited (14.0%), Divi's Laboratories Limited (9.2%), Lupin Limited (8.2%); the ten largest together made up 60.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 77.0% of its equity. Cash and debt stood at 1.4%. Compared with Dec 2024 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
85%
Top-10 weight is higher than 85% of peers
Breadth
34%
Holds more stocks than 34% of peers
Cash
19%
Holds more cash than 19% of peers
Holdings in January 2025
Download CSVEvery line the fund disclosed, with the change against Dec 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 14.01%
- Δ weight
- up 0.14 pts
- Value
- ₹1,143 Cr
- Δ value
- down ₹93.4 Cr
- Status
- Trimmed
- Weight
- 9.23%
- Δ weight
- down 0.01 pts
- Value
- ₹753 Cr
- Δ value
- down ₹70.4 Cr
- Status
- Trimmed
- Weight
- 8.16%
- Δ weight
- down 0.31 pts
- Value
- ₹666 Cr
- Δ value
- down ₹88.8 Cr
- Status
- Trimmed
- Weight
- 5.62%
- Δ weight
- up 0.30 pts
- Value
- ₹459 Cr
- Δ value
- down ₹15.4 Cr
- Status
- Trimmed
- Weight
- 5.46%
- Δ weight
- down 0.24 pts
- Value
- ₹446 Cr
- Δ value
- down ₹62.7 Cr
- Status
- Trimmed
- Weight
- 5.41%
- Δ weight
- up 0.10 pts
- Value
- ₹442 Cr
- Δ value
- down ₹31.5 Cr
- Status
- Trimmed
- Weight
- 3.61%
- Δ weight
- up 0.02 pts
- Value
- ₹294 Cr
- Δ value
- down ₹25.5 Cr
- Status
- Trimmed
- Weight
- 3.17%
- Δ weight
- up 0.01 pts
- Value
- ₹258 Cr
- Δ value
- down ₹22.8 Cr
- Status
- Trimmed
- Weight
- 3.16%
- Δ weight
- down 0.16 pts
- Value
- ₹258 Cr
- Δ value
- down ₹38.3 Cr
- Status
- Trimmed
- Weight
- 2.86%
- Δ weight
- down 0.14 pts
- Value
- ₹233 Cr
- Δ value
- down ₹33.7 Cr
- Status
- Trimmed
- Weight
- 2.77%
- Δ weight
- down 0.11 pts
- Value
- ₹226 Cr
- Δ value
- down ₹30.8 Cr
- Status
- Trimmed
- Weight
- 2.55%
- Δ weight
- up 0.41 pts
- Value
- ₹208 Cr
- Δ value
- up ₹17.2 Cr
- Status
- Added
- Weight
- 2.45%
- Δ weight
- down 0.10 pts
- Value
- ₹200 Cr
- Δ value
- down ₹27.7 Cr
- Status
- Trimmed
- Weight
- 2.38%
- Δ weight
- up 0.20 pts
- Value
- ₹194 Cr
- Δ value
- down ₹29 L
- Status
- Held
- Weight
- 2.24%
- Δ weight
- down 0.18 pts
- Value
- ₹182 Cr
- Δ value
- down ₹33.3 Cr
- Status
- Trimmed
- Weight
- 2.16%
- Δ weight
- down 0.48 pts
- Value
- ₹176 Cr
- Δ value
- down ₹59.5 Cr
- Status
- Trimmed
- Weight
- 2.02%
- Δ weight
- down 0.09 pts
- Value
- ₹165 Cr
- Δ value
- down ₹22.9 Cr
- Status
- Trimmed
- Weight
- 2.02%
- Δ weight
- up 0.12 pts
- Value
- ₹165 Cr
- Δ value
- down ₹4.6 Cr
- Status
- Trimmed
- Weight
- 1.77%
- Δ weight
- down 0.12 pts
- Value
- ₹144 Cr
- Δ value
- down ₹23.7 Cr
- Status
- Trimmed
- Weight
- 1.73%
- Δ weight
- down 0.08 pts
- Value
- ₹141 Cr
- Δ value
- down ₹20.1 Cr
- Status
- Trimmed
- Weight
- 1.72%
- Δ weight
- down 0.03 pts
- Value
- ₹140 Cr
- Δ value
- down ₹15.8 Cr
- Status
- Trimmed
- Weight
- 1.70%
- Δ weight
- down 0.15 pts
- Value
- ₹139 Cr
- Δ value
- down ₹26.5 Cr
- Status
- Trimmed
- Weight
- 1.56%
- Δ weight
- down 0.02 pts
- Value
- ₹127 Cr
- Δ value
- down ₹13.8 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.36%
- Δ weight
- down 0.50 pts
- Value
- ₹111 Cr
- Δ value
- down ₹54.8 Cr
- Status
- Trimmed
- Weight
- 1.23%
- Δ weight
- up 0.05 pts
- Value
- ₹100 Cr
- Δ value
- down ₹5.1 Cr
- Status
- Trimmed
- Weight
- 1.20%
- Δ weight
- down <0.01 pts
- Value
- ₹98.1 Cr
- Δ value
- down ₹9.4 Cr
- Status
- Trimmed
- Weight
- 1.10%
- Δ weight
- up 0.64 pts
- Value
- ₹89.6 Cr
- Δ value
- up ₹49.2 Cr
- Status
- Added
- Weight
- 1.03%
- Δ weight
- down 0.05 pts
- Value
- ₹84 Cr
- Δ value
- down ₹12.6 Cr
- Status
- Trimmed
- Weight
- 1.01%
- Δ weight
- up 1.01 pts
- Value
- ₹82.8 Cr
- Δ value
- up ₹82.8 Cr
- Status
- New
- Weight
- 1.01%
- Δ weight
- up 0.04 pts
- Value
- ₹82.5 Cr
- Δ value
- down ₹4.3 Cr
- Status
- Trimmed
- Weight
- 0.88%
- Δ weight
- up 0.34 pts
- Value
- ₹71.4 Cr
- Δ value
- up ₹24.1 Cr
- Status
- Added
- Weight
- 0.85%
- Δ weight
- down 0.41 pts
- Value
- ₹69.6 Cr
- Δ value
- down ₹43 Cr
- Status
- Trimmed
- Weight
- 0.57%
- Δ weight
- up 0.04 pts
- Value
- ₹46.4 Cr
- Δ value
- down ₹45 L
- Status
- Trimmed
- Weight
- 0.56%
- Δ weight
- down 0.12 pts
- Value
- ₹45.9 Cr
- Δ value
- down ₹15.1 Cr
- Status
- Trimmed
- Weight
- 0.45%
- Δ weight
- down 0.04 pts
- Value
- ₹36.9 Cr
- Δ value
- down ₹6.6 Cr
- Status
- Trimmed
- Weight
- 0.36%
- Δ weight
- down 0.14 pts
- Value
- ₹29.3 Cr
- Δ value
- down ₹14.8 Cr
- Status
- Trimmed
- Weight
- 0.34%
- Δ weight
- up 0.03 pts
- Value
- ₹28.1 Cr
- Δ value
- up ₹52 L
- Status
- Added
- Weight
- 0.30%
- Δ weight
- up 0.02 pts
- Value
- ₹24.1 Cr
- Δ value
- down ₹63 L
- Status
- Trimmed
What changed, Dec 2024 to Jan 2025
New New positions (1)
- Biocon Limited1.0% · ₹82.8 Cr
Exited Exited (0)
None.
Added Biggest additions
- IPCA Laboratories Limitedup ₹49.2 Cr (+0.64% pts)
- Sai Life Sciences Limitedup ₹24.1 Cr (+0.34% pts)
- Narayana Hrudayalaya Limitedup ₹17.2 Cr (+0.41% pts)
- Krishna Institute Of Medical Sciences Limitedup ₹52 L (+0.03% pts)
Biggest reductions
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2024, the weight rose most in Pharmaceuticals & Biotechnology (+0.2 pts), and fell most in Retailing (−0.2 pts) and Pharmaceuticals (−0.1 pts).
- Pharmaceuticals & Biotechnology76.8% → 77.0%+0.2 pts
- Retailing3.4% → 3.2%−0.2 pts
- Pharmaceuticals0.7% → 0.6%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2022 | Jan 2024 | Jul 2024 | Oct 2024 | Dec 2024 | Jan 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 75.3% | 77.4% | 79.2% | 78.7% | 76.8% | 77.0% |
| Healthcare Services | 22.3% | 18.2% | 17.4% | 18.2% | 19.1% | 19.2% |
| Retailing | — | 3.2% | 2.6% | 2.5% | 3.4% | 3.2% |
| Pharmaceuticals | 1.8% | 1.0% | 0.8% | 0.7% | 0.7% | 0.6% |
Allocation in Jan 2025change vs Dec 2024
- Pharmaceuticals & Biotechnology (25)77.0%▲ 0.2 pts
- Healthcare Services (10)19.2%▲ 0.1 pts
- Retailing (1)3.2%▼ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jan 2025
1.4%
▼ 0.5 pts vs Dec 2024
- Cash alone
- 1.4%
- cash and net receivables
- A year earlier
- 0.8%
- Jan 2024 · now ▲ 0.6 pts
- Last 12 months
- 0.6% – 4.4%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.